Literature DB >> 32897884

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.

Justin Taylor1,2, Mark Ta Donoghue3, Caleb Ho4, Kseniya Petrova-Drus4, Hikmat A Al-Ahmadie4, Samuel A Funt5, Yanming Zhang4, Umut Aypar4, Pavitra Rao3, Shweta S Chavan3, Michael Haddadin1, Roni Tamari6, Sergio Giralt6, Martin S Tallman7, Raajit K Rampal7, Priscilla Baez1, Rajya Kappagantula1, Satyajit Kosuri6, Ahmet Dogan4, Satish K Tickoo4, Victor E Reuter4, George J Bosl5, Christine A Iacobuzio-Donahue1,4, David B Solit1,3,5, Barry S Taylor1,3,8, Darren R Feldman5, Omar Abdel-Wahab1,7.   

Abstract

Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor outcomes. One in every 17 patients with primary mediastinal nonseminomatous GCTs develop an incurable hematologic malignancy and prior data intriguingly suggest a clonal relationship exists between hematologic malignancies and GCTs in these cases. To date, however, the precise clonal relationship between GCTs and the diverse additional somatic malignancies arising in such individuals have not been determined. Here, we traced the clonal evolution and characterized the genetic features of each neoplasm from a cohort of 15 patients with GCTs and associated hematologic malignancies. We discovered that GCTs and hematologic malignancies developing in such individuals evolved from a common shared precursor, nearly all of which harbored allelically imbalanced p53 and/or RAS pathway mutations. Hematologic malignancies arising in this setting genetically resembled mediastinal GCTs rather than de novo myeloid neoplasms. Our findings argue that this scenario represents a unique clinical syndrome, distinct from de novo GCTs or hematologic malignancies, initiated by an ancestral precursor that gives rise to the parallel evolution of GCTs and blood cancers in these patients.

Entities:  

Keywords:  Cancer; Genetics; Hematology; Leukemias

Year:  2020        PMID: 32897884      PMCID: PMC7685753          DOI: 10.1172/JCI139682

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.

Authors:  Ronglai Shen; Venkatraman E Seshan
Journal:  Nucleic Acids Res       Date:  2016-06-07       Impact factor: 16.971

Review 2.  Testicular cancer--discoveries and updates.

Authors:  Nasser H Hanna; Lawrence H Einhorn
Journal:  N Engl J Med       Date:  2014-11-20       Impact factor: 91.245

3.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.

Authors:  Catherine C Coombs; Ahmet Zehir; Sean M Devlin; Ashwin Kishtagari; Aijazuddin Syed; Philip Jonsson; David M Hyman; David B Solit; Mark E Robson; José Baselga; Maria E Arcila; Marc Ladanyi; Martin S Tallman; Ross L Levine; Michael F Berger
Journal:  Cell Stem Cell       Date:  2017-08-10       Impact factor: 24.633

4.  High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.

Authors:  Nabil Adra; Rafat Abonour; Sandra K Althouse; Costantine Albany; Nasser H Hanna; Lawrence H Einhorn
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

5.  Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.

Authors:  R J Motzer; A Amsterdam; V Prieto; J Sheinfeld; V V Murty; M Mazumdar; G J Bosl; R S Chaganti; V E Reuter
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

6.  Association between mediastinal germ cell tumors and hematologic malignancies. Report of two cases and review of the literature.

Authors:  S H DeMent; J C Eggleston; J L Spivak
Journal:  Am J Surg Pathol       Date:  1985-01       Impact factor: 6.394

7.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

Review 8.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

9.  Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor.

Authors:  Benjamin R Oshrine; Molly N Olsen; Mallorie Heneghan; Gerald Wertheim; Robert Daber; Donna M Wilmoth; Jaclyn A Biegel; Bruce Pawel; Richard Aplenc; Rebecca L King
Journal:  Cancer Genet       Date:  2014-04-05

10.  A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Charles Lu; Peter Riedell; Christopher A Miller; Ian S Hagemann; Peter Westervelt; Bradley A Ozenberger; Michelle O'Laughlin; Vincent Magrini; Ryan T Demeter; Eric J Duncavage; Malachi Griffith; Obi L Griffith; Lukas D Wartman
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-01
View more
  5 in total

1.  Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.

Authors:  Hiroshi Yaegashi; Takahiro Nohara; Kazuyoshi Shigehara; Kouji Izumi; Yoshifumi Kadono; Tomoyuki Makino; Kaname Yamashita; Koushiro Ohtsubo; Hiroko Ikeda; Atsushi Mizokami
Journal:  Cancer Diagn Progn       Date:  2022-05-03

Review 2.  Mediastinal germ cell tumours: where we are and where we are going-a narrative review.

Authors:  Laura Marandino; Ursula Maria Vogl
Journal:  Mediastinum       Date:  2022-03-25

3.  Malignant histiocytosis associated with mediastinal germ cell tumor: A case report.

Authors:  Pei-Yi Yang; Xiao-Li Ma; Wen Zhao; Li-Bing Fu; Rui Zhang; Qi Zeng; Hong Qin; Tong Yu; Yan Su
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

4.  Acute Mast Cell Leukemia Preceded by Malignant Mediastinal Germ Cell Tumor: A Case Report and Literature Review.

Authors:  Huafang Wang; Yuan Chen; Huijun Lin; Wanmao Ni; Qiaolei Zhang; Jianping Lan; Lai Jin
Journal:  Cancer Manag Res       Date:  2022-05-23       Impact factor: 3.602

Review 5.  To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm.

Authors:  Massimo De Felici; Francesca Gioia Klinger; Federica Campolo; Carmela Rita Balistreri; Marco Barchi; Susanna Dolci
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.